Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 13Phase NA 8Phase 3 5Phase 1/2 4Phase EARLY_PHASE1 2Phase 4 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Endocrine 1

Conditions

Breast Neoplasms 182Neoplasms 115Prostatic Neoplasms 103Multiple Myeloma 86Glioblastoma 82Pancreatic Neoplasms 76Glioma 66Brain Neoplasms 60Lung Neoplasms 58Head and Neck Neoplasms 57Melanoma 55Colorectal Neoplasms 55Carcinoma, Non-Small-Cell Lung 53Leukemia, Myeloid, Acute 51Carcinoma, Hepatocellular 51Recurrence 47Squamous Cell Carcinoma of Head and Neck 46Ovarian Neoplasms 45Lymphoma 40Lymphoma, Non-Hodgkin 37Sarcoma 36Lymphoma, B-Cell 36Stomach Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 34Solid Tumor 31Hematologic Neoplasms 31Carcinoma, Renal Cell 30Polycystic Ovary Syndrome 27Burkitt Lymphoma 27

Interventions

tocilizumab 1Liraglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Craniopharyngioma × Clear all
NCT03970226 2026-02-17

Tocilizumab in Children With ACP

University of Colorado, Denver

Phase EARLY_PHASE1 Active not recruiting
9 enrolled
CNS

Craniopharyngioma

NCT06217848 2024-01-23

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Seoul National University Hospital

Phase EARLY_PHASE1 Unknown
50 enrolled
CNSEndocrine

Combined Pituitary Hormone Deficiency, Craniopharyngioma, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡